{"id":"placebo-for-rosuvastatin-20mg","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1744447","moleculeType":"Small molecule","molecularWeight":"1001.15"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is used as a control in clinical trials to establish the true efficacy of an active drug by comparison. It contains no active ingredient and produces no direct therapeutic effect, allowing researchers to measure the drug's actual benefit independent of psychological or natural disease progression effects.","oneSentence":"Placebo is an inert substance with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:19.239Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in phase 3 trial for Rosuvastatin 20mg (hyperlipidemia/cardiovascular risk reduction)"}]},"trialDetails":[{"nctId":"NCT05850091","phase":"PHASE4","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-07","conditions":"Coronary Artery Disease","enrollment":200},{"nctId":"NCT07232069","phase":"PHASE3","title":"PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-07-01","conditions":"Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control","enrollment":1500},{"nctId":"NCT07303816","phase":"PHASE4","title":"Statins to Prevent Cancer Associated Blood Clots","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-04-01","conditions":"Venous Thromboembolism, Cancer, Cardiovascular Events","enrollment":4000},{"nctId":"NCT07254221","phase":"PHASE4","title":"Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Shiraz University of Medical Sciences","startDate":"2026-02-01","conditions":"Anthracycline-induced Cardiac Toxicity, Breast Cancer, Anthracycline Related Cardiotoxicity in Breast Cancer","enrollment":400},{"nctId":"NCT06924684","phase":"PHASE2","title":"High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sheikh Zayed Federal Postgraduate Medical Institute","startDate":"2024-12-02","conditions":"ST Elevation (STEMI) Myocardial Infarction","enrollment":66},{"nctId":"NCT02008786","phase":"PHASE4","title":"Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD","status":"TERMINATED","sponsor":"Cardiology Research UBC","startDate":"2014-06","conditions":"Coronary Artery Dissection, Spontaneous","enrollment":18},{"nctId":"NCT02901067","phase":"PHASE2","title":"STAT-STatin and Aspirin in Trauma","status":"TERMINATED","sponsor":"Denver Health and Hospital Authority","startDate":"2017-02-03","conditions":"Wounds and Injuries, Venous Thromboembolism","enrollment":43},{"nctId":"NCT02850081","phase":"PHASE3","title":"Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-06-01","conditions":"Carotid Artery Stenosis, Strokes","enrollment":31},{"nctId":"NCT03889314","phase":"PHASE4","title":"The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial","status":"UNKNOWN","sponsor":"Minneapolis Heart Institute Foundation","startDate":"2019-04-26","conditions":"Cardiovascular Risk Factor, Cardiovascular Diseases, Adverse Effect","enrollment":25},{"nctId":"NCT02546323","phase":"PHASE3","title":"A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-09-17","conditions":"Atherosclerosis","enrollment":543},{"nctId":"NCT02977065","phase":"PHASE2","title":"To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2017-03-23","conditions":"Dyslipidemias","enrollment":62},{"nctId":"NCT02546648","phase":"PHASE3","title":"PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study","status":"COMPLETED","sponsor":"McMaster University","startDate":"2015-02","conditions":"Atherosclerotic Disease, Perioperative Bleeding","enrollment":100},{"nctId":"NCT02434497","phase":"PHASE3","title":"A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-06-06","conditions":"Homozygous Familial Hypercholesterolemia (HoFH)","enrollment":9},{"nctId":"NCT02226198","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-11","conditions":"Homozygous Familial Hypercholesterolemia (HoFH)","enrollment":20},{"nctId":"NCT02551172","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD","status":"UNKNOWN","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2014-10","conditions":"Hyperlipidemias","enrollment":270},{"nctId":"NCT01170585","phase":"PHASE2","title":"A Trial of Rosuvastatin in Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2010-07","conditions":"Atherosclerosis, Systemic Lupus Erythematosus","enrollment":33},{"nctId":"NCT02445352","phase":"PHASE3","title":"Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia","status":"COMPLETED","sponsor":"Alvogen Korea","startDate":"2014-07","conditions":"Primary Hypercholesterolemia","enrollment":379},{"nctId":"NCT01918332","phase":"PHASE3","title":"Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia","status":"COMPLETED","sponsor":"LG Life Sciences","startDate":"2012-04","conditions":"Hypertension,, Hyperlipidemia","enrollment":168},{"nctId":"NCT01364220","phase":"PHASE3","title":"The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke","status":"TERMINATED","sponsor":"Severance Hospital","startDate":"2010-08","conditions":"Stroke","enrollment":318},{"nctId":"NCT02087540","phase":"PHASE3","title":"Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia","status":"UNKNOWN","sponsor":"IlDong Pharmaceutical Co Ltd","startDate":"2013-05","conditions":"Hypertension, Hyperlipidemia","enrollment":310},{"nctId":"NCT01624857","phase":"PHASE3","title":"Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2012-06","conditions":"Coronary Heart Disease","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo(for Rosuvastatin 20mg)","genericName":"Placebo(for Rosuvastatin 20mg)","companyName":"IlDong Pharmaceutical Co Ltd","companyId":"ildong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo is an inert substance with no active pharmacological mechanism. Used for Control arm in phase 3 trial for Rosuvastatin 20mg (hyperlipidemia/cardiovascular risk reduction).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}